major depression

Acadia fails in attempt to expand use of antipsychotic to treat patients with depression
Acadia fails in attempt to expand use of antipsychotic to treat patients with depression
Stat
Acadia Pharma
clinical trials
major depression
Nuplazid
major depressive disorder
antipsychotics
Flag link:
Trump touted a new antidepressant as a solution for veterans. Only 15 have been treated
Trump touted a new antidepressant as a solution for veterans. Only 15 have been treated
Stat
Donald Trump
veterans
esketamine
major depression
Spravato
JNJ
Janssen
Flag link:
FDA approves Janssen's fast-acting depression therapy esketamine
FDA approves Janssen's fast-acting depression therapy esketamine
BioCentury
FDA
Spravato
esketamine
Janssen
JNJ
major depression
Flag link:
The psychiatry field is buzzing with anticipation — and hesitation — about esketamine for depression
The psychiatry field is buzzing with anticipation — and hesitation — about esketamine for depression
Stat
major depression
esketamine
JNJ
FDA
psychiatrists
Flag link:
FDA experts offer a big thumbs up for J&J’s flawed application to market esketamine for major depression — but trial failures, safety questions spur concerns
FDA experts offer a big thumbs up for J&J’s flawed application to market esketamine for major depression — but trial failures, safety questions spur concerns
Endpoints
JNJ
FDA
advisory panels
esketamine
major depression
Flag link:
J&J’s Esketamine for Depression Faces an FDA Panel Next Week
J&J’s Esketamine for Depression Faces an FDA Panel Next Week
BioSpace
JNJ
FDA
esketamine
major depression
Flag link:
J&J racks up a fresh set of positive pivotal data for depression drug esketamine — but questions linger on safety
J&J racks up a fresh set of positive pivotal data for depression drug esketamine — but questions linger on safety
Endpoints
JNJ
esketamine
major depression
Flag link:
Costs Of Treating Those With Diagnosed Depression Eclipses $10,000
Costs Of Treating Those With Diagnosed Depression Eclipses $10,000
Forbes
major depression
healthcare costs
Flag link:
With hits and misses in first pivotal trials, J&J confidently maps a path to the FDA with its major depression med esketamine
With hits and misses in first pivotal trials, J&J confidently maps a path to the FDA with its major depression med esketamine
Endpoints
JNJ
esketamine
major depression
Flag link:
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
CP Wire
JNJ
esketamine
depression
major depression
Flag link:
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
JNJ
esketamine
depression
major depression
Flag link:
J&J’s big blockbuster hopeful esketamine scores high for major depression — but side effects haunt results
J&J’s big blockbuster hopeful esketamine scores high for major depression — but side effects haunt results
Endpoints
JNJ
esketamine
major depression
Flag link:
Depression Drug That Works in One Day Passes Key Test
Depression Drug That Works in One Day Passes Key Test
Forbes
major depression
Naurex
NRX-1074
Flag link: